Martin Korbling

Title: Martin Korbling: Innovator in Extracorporeal Ablation Technologies

Introduction

Martin Korbling is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of medical technology, particularly in the area of extracorporeal ablation of circulating cells. His innovative approach aims to improve the treatment of various diseases, including cancer.

Latest Patents

Korbling holds a patent for "Devices and methods for extracorporeal ablation of circulating cells." This patent describes methods and devices designed for the extracorporeal ablation of target cells circulating in the blood of an organism. The technology involves introducing exogenous material into the bloodstream that preferentially associates with target cells, such as cancer cells, bacteria, and viruses. An extracorporeal continuous flow pathway is utilized to access the patient's blood, allowing an external energy source to be applied at an ex vivo ablation device. This process minimizes the shielding of target cells by the body, thereby reducing detrimental effects on organs and tissues.

Career Highlights

Martin Korbling is currently associated with Nanospectra Biosciences, Inc., where he continues to develop and refine his innovative technologies. His work is pivotal in advancing medical treatments that target harmful cells while preserving healthy tissues.

Collaborations

Some of his notable coworkers include J Donald Payne and Christopher L Coleman, who contribute to the collaborative efforts at Nanospectra Biosciences, Inc. Their combined expertise enhances the development of cutting-edge medical technologies.

Conclusion

Martin Korbling's contributions to the field of extracorporeal ablation represent a significant advancement in medical technology. His innovative methods have the potential to transform the treatment landscape for various diseases, particularly cancer.